Risk-adapted moderate hypofractionation of prostate cancer : A prospective analysis of acute toxicity, QOL and outcome in 221 patients.

Strahlenther Onkol · 2019 · PMC6763405 · PMID 31139841

Europe PMC DOI

hedged sentence

0.0680

closest p · 1.4× alpha

0.0680

boldest claim

The sentences

failed to reach significancep = 0.068so close (0.05 < p ≤ 0.1)

In HR patients the increase was slightly more pronounced, but the difference failed to reach significance compared to LR ( p = 0.068) and IR ( p = 0.090).

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.